Literature DB >> 10690174

Possible involvement of IL-12 expression by Epstein-Barr virus in Sjögren syndrome.

M Horiuchi1, S Yamano, H Inoue, J Ishii, Y Nagata, H Adachi, M Ono, J N Renard, F Mizuno, Y Hayashi, I Saito.   

Abstract

AIM: To determine the correlation between interleukin 12 (IL-12) expression and Epstein-Barr virus (EBV) in Sjögren syndrome.
METHODS: Indirect immunohistochemical technique, enzyme linked immunosorbent assay (ELISA), and immunoblot analysis were used to investigate IL-12 expression by EBV activation, using 13 surgical specimens and four B cell lines.
RESULTS: Marked expression of IL-12 was found in the epithelial cells and the infiltrating B cells of salivary gland tissues from patients with Sjögren syndrome (six of 10 cases), but not in those from normal individuals (none of three cases). A striking topographic correlation between IL-12 and EBV was found. In addition, levels of IL-12 production by B cell lines were clearly enhanced by EBV activation in vitro.
CONCLUSIONS: IL-12 expression closely reflects the intracellular event of EBV activation in Sjögren syndrome, and may contribute to the T helper cell type 1 (Th1) cytokine overexpression seen in this disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10690174      PMCID: PMC501596          DOI: 10.1136/jcp.52.11.833

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  39 in total

1.  Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts.

Authors:  R S Chang; J P Lewis; R D Reynolds; M J Sullivan; J Neuman
Journal:  Ann Intern Med       Date:  1978-01       Impact factor: 25.391

2.  Site of Epstein-Barr virus replication in the oropharynx.

Authors:  D G Morgan; J C Niederman; G Miller; H W Smith; J M Dowaliby
Journal:  Lancet       Date:  1979-12-01       Impact factor: 79.321

3.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

Authors:  J Countryman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

4.  trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.

Authors:  K Takada; N Shimizu; S Sakuma; Y Ono
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

5.  Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population.

Authors:  R S Chang; J P Lewis; C F Abildgaard
Journal:  N Engl J Med       Date:  1973-12-20       Impact factor: 91.245

6.  Persistence of Epstein-Barr virus in the parotid gland.

Authors:  H Wolf; M Haus; E Wilmes
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

Review 7.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

8.  Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies.

Authors:  T C Adamson; R I Fox; D M Frisman; F V Howell
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

9.  Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.

Authors:  J Menezes; M Jondal; W Leibold; G Dorval
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

10.  Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-gamma in rheumatoid arthritis.

Authors:  M Lotz; C D Tsoukas; S Fong; C A Dinarello; D A Carson; J H Vaughan
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

View more
  6 in total

Review 1.  The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms.

Authors:  Amy Donate; Alexandria Voigt; Cuong Q Nguyen
Journal:  Expert Rev Clin Immunol       Date:  2014-02-10       Impact factor: 4.473

Review 2.  Is it Sjögren's syndrome or burning mouth syndrome? Distinct pathoses with similar oral symptoms.

Authors:  Hawra Aljanobi; Amarpreet Sabharwal; Bralavan Krishnakumar; Jill M Kramer
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2017-01-24

Review 3.  The role of epithelial cells in the pathogenesis of Sjögren's syndrome.

Authors:  Menelaos N Manoussakis; Efstathia K Kapsogeorgou
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 4.  Autoimmunity and infection in Sjögren's syndrome.

Authors:  Ann Igoe; R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

5.  Targeting the Ca(2+) Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome.

Authors:  Alessia Gallo; Shyh-Ing Jang; Hwei Ling Ong; Paola Perez; Mayank Tandon; Indu Ambudkar; Gabor Illei; Ilias Alevizos
Journal:  EBioMedicine       Date:  2016-06-29       Impact factor: 8.143

Review 6.  Role of Viral Infections in the Pathogenesis of Sjögren's Syndrome: Different Characteristics of Epstein-Barr Virus and HTLV-1.

Authors:  Hideki Nakamura; Toshimasa Shimizu; Atsushi Kawakami
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.